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Purpose. To determine the eﬀect of the isolation technique and location upon the phenotype of human corneal stroma-derived cells
(CSCs). Methods. CSCs were isolated from the corneal stroma center and periphery using the explant or enzymatic digestion
technique. The native tissue was stained for functional markers, while cultured cells were analysed by FACS. PCR was used to
determine gene expression in the cultured versus native cells. Results. The native stroma was positive for α-actinin, ALDH1A1,
CD31, CD34, Collagen I, and Vimentin. Cultured cells expressed CD73, CD90, CD105, CD51, Nestin, CD49a, CD49d, ABCG2,
and CD47. PCR demonstrated a signiﬁcant upregulation of ALDH1A1, AQP1, ITGB4, KLF4, CD31, CD34, and CXCR4 in the
native tissue, while the expression of ABCG2, ITGAV, Nestin, CD73, CD90, CD105, and Vimentin were signiﬁcantly higher in
the cultured cells. GPC did not change. Conclusion. The study ﬁnds no signiﬁcant diﬀerence between the phenotype of CSCs
generated by the explant or enzymatic digestion technique from the center or periphery of the stroma. Isolation of the cells can
be performed without regard to the location and isolation technique used for research. Cultivated CSCs undergo a complete
surface marker and genotype proﬁle change compared to the state in situ.
1. Introduction
The human corneal stroma is responsible for two-thirds of
the refractive power of the eye and occupies 90% of the cor-
neal thickness. When aﬀected by disease or trauma, the
homeostasis and thus transparency of the tissue is compro-
mised. This is partially due to presence of local edema and
activation of resident corneal cells—keratocytes. These quies-
cent cells assume a dendritic cell morphology in vivo and
synthesize collagens and proteoglycans forming the backbone
of the tissue [1]; when activated, keratocytes can transform
into myoﬁbroblasts, associated with scar formation and ulti-
mately loss of corneal transparency [2, 3]. Treatment for such
cases usually involves lamellar or penetrating keratoplasty,
but due to donor scarcity worldwide, alternative sources are
seeked upon, such as bioengineered or decellularised corneas
or prostheses [4, 5].
Cells derived from the human corneal stroma have been
shown to possess trilineage diﬀerentiation potential and pres-
ence or absence of speciﬁc markers (e.g., CD73+, CD90+,
CD105+, CD34−, CD45−, CD14−, CD11b−, CD79α−, CD19−,
and HLA-DR−), while adherence to plastic and exposure to
serum render these cells equivalent tomesenchymal stem cells
(MSCs) [6, 7]. Moreover, the immunosuppressive potential of
CSCs has been demonstrated previously [8, 9], as well as their
cell therapy potential in animal studies [10].
Establishment of CSC cultures is relatively easy. Never-
theless, many countries have access only to peripheral tissue
remaining in unused corneal rings after keratoplasty. Use of
enzymatic digestion to isolate CSCs out of the tightly packed
collagen layers appears straightforward as well [11, 12], while
the explant culture method of isolating pieces of corneal tis-
sue to produce cells ex vivo has already been established.
Many speculations yet remain about the true origin of the
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outgrowing cells from the corneal stroma ex vivo [9, 12].
Most likely, it is the resident cells of the corneal stroma that
get activated after isolation and possibly diﬀerent side popu-
lations become dominant, eventually generating a culture of
cells displaying a ﬁbroblastoid morphology [9, 13, 14].
Various types of culture media have also been assessed to
elucidate the best possible conditions for induction of in vitro
stem cell phenotype in these cells [15]; however, no compar-
ison to date has been carried out to determine whether cells
isolated from diﬀerent locations (cornea center versus
periphery) display any diﬀerence. The present study aims to
establish cornea stromal cultures by explant and enzymatic
digestion methods from central and peripheral parts of the
cornea and compare their phenotypical and genotypical
properties for future application of these cells in corneal
research or cell therapy purposes.
2. Materials and Methods
2.1. Isolation Procedure and Cultivation. Cadaveric tissue
collection complied with the directive of the Helsinki
Declaration and was approved by the National Medical
Research Council (14387/2013/EKU-182/2013). Samples
were obtained within 24 hours from death. Following disin-
fection by povidone iodine (Egis, Hungary) and rinsing
with PBS of human bulbi, corneal buttons were dissected
using scissors. The corneal epithelium, Descemet’s mem-
brane, and corneal endothelium were peeled oﬀ. To obtain
equal-sized stromal explants, pieces of tissue measuring
3mm in diameter were punched out from the corneal but-
tons with the help of a trephine from regions deﬁned as the
peripheral versus the central stroma, as shown in Figure 1.
An equal number of punches were generated from the cen-
tral versus peripheral regions in the same way described
above and treated with 3mg/mL (>125CDU/mg) mixed
collagenase solution (Sigma-Aldrich, St. Louis, MO, USA)
for 3 hours at 37°C, with agitation.
Four types of CSC cultures were deﬁned as central explant
(CE) and peripheral explant (PE) versus central digested (CD)
and peripheral digested (PD) from the same donors, referring
to the location and presence or absence of enzymatic diges-
tion, respectively. 24-well plates (Corning Costar, Sigma-
Aldrich) were used to expand the cells. Dulbecco’s Modiﬁed
EagleMedium (DMEM) (Sigma-Aldrich) supplemented with
10% Fetal bovine serum (FBS) (Sigma-Aldrich) and 1%
penicillin-streptomycin (PS) (Sigma-Aldrich) was applied to
the cells. Culturemedia was changed every alternate day. Cells
up to passage 4 were used for the experiments.
2.2. Immunoﬂuorescent Staining for Proliferation Marker
Ki-67 in Cultured CSCs. CD, PD, CE, and PE were expanded
in 24-well culture plates (Corning Costar). Cells were ﬁxed
in 4% paraformaldehyde (Sigma-Aldrich) and permeabilised
using 0.1% Triton X-100 (Sigma-Aldrich). Bovine serum
albumin (BSA) 1% (Sigma-Aldrich) diluted in phosphate-
buﬀered saline (PBS) was applied as a blocking solution for
1 hour at room temperature. Samples were incubated with
the primary Ki-67 (Sigma-Aldrich) antibody for 1 hour at
room temperature. A phycoerythrin-conjugated secondary
antibody was used to visualize the protein and ﬁnally, 4′,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich) counter-
staining to stain the cell nuclei. Pictures were taken by an
EVOS FL microscope (Thermo Fisher Scientiﬁc).
2.3. Immunoﬂuorescent Staining of Native Corneal Tissue.
For studying the protein expression in situ, corneal sec-
tions were prepared from paraﬃn-embedded tissues and
stained for markers expressed by progenitor and/or stem
cells (ABCG2, CXCR4, and Nestin). Proliferation- (Ki-67),
function-related (ALDH1A1, Collagen I, and CD34), and
MSCmarkers (CD73,CD90,CD105, andVimentin), extracel-
lularmatrix and cell-adhesion components (Fibronectin, Col-
lagen IV, and VE-Cadherin), and other molecules (α-actinin,
ABCG5, and antiﬁbroblast marker) were stained. More
information about the antibodies used is shown in Table S1
available online at https://doi.org/10.1155/2017/9275248.
In brief, sections were deparaﬃnised and the nonspe-
ciﬁc sites were blocked by 1% BSA (Sigma-Aldrich) for
1 hour at room temperature. Primary antibodies were
applied overnight at 4°C. Following three times 5-minute
wash by PBS containing 1% Tween-20 (PBST), Alexa
Fluor 488 conjugated secondary antibodies were incubated
on the sections for 1 hour at room temperature. DAPI
counterstaining was performed to visualize the nuclei.
Pictures were taken by a Zeiss Axio Observer Z1 (Carl
Zeiss) microscope.
2.4. Fluorescence-Activated Cell Sorting (FACS). CSCs were
subcultured in 150 cm2 ﬂasks (TPP, Sigma Aldrich) for FACS
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Figure 1: Anatomical features of the human cornea and sites of stromal cell isolation. Pieces of tissue were punched out from the indicated
central and peripheral corneal regions by a surgical trephine (3mm) for consequent digestion and/or culturing. The picture was taken by a
phase contrast microscope and put together as an overlay (EVOS® FL microscope, Thermo Fisher Scientiﬁc).
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analyses. Cells were collected by trypsinisation (Hyclone, GE
Healthcare Life Sciences, Logan, Utah, USA) for surface
protein expression analyses. After centrifugation at 1000
RPM, for 10 minutes, the cells were resuspended in FACS
buﬀer (0.05% Na-azide and 0.5% BSA in DPBS). Three-
color staining—ﬂuorescein-isothiocyanate, phycoerythrin,
and allophycocyanin-conjugated primary antibodies against
ABCG2, CD31, CD34, CD44, CD47, CD49a, CD49d,
CD51, CD73, CD90, CD105, and Nestin—were applied for
30 minutes at 4°C. FACS Calibur cytometer (BD Biosciences,
Immunocytometry Systems) was used to measure the sam-
ples. Finally, data were analysed by Flowing Software 2.5
(Perttu Terho, Turku Centre for Biotechnology, University
of Turku, Finland) and FCS Express 6 (De Novo Software,
California, USA). More information about the antibodies is
provided in Table S2.
2.5. Reverse Transcription-Quantitative Polymerase Chain
Reaction (RT-qPCR) Analysis. Native corneal stroma tissue
free of epithelium and endothelium was collected from 3
donors. The tissue from the donors was homogenized and
pooled. Total RNA was isolated by Qiazol reagent (Qiagen)
and RNeasy mini kit (Qiagen) following the manufacturer’s
protocol. Similarly, total RNA was isolated from cultured
cells separately for the 4 deﬁned conditions by the RNeasy
mini kit and pooled from 3 donors.
Nucleic acid concentrations were determined by a
NanoDrop spectrophotometer (Thermo Fisher Scientiﬁc).
Random hexamers and Superscript III reverse transcriptase
(Life Technologies, Waltham, MA, USA) were used to tran-
scribe 1μg RNA into cDNA. StepOnePlus RT-PCR system
(Applied Biosystems) and Taqman Gene Expression assays
were used to determine relative gene expression levels. Genes
ALDH1A1 (Hs00605167_g1), ABCG2 (Hs01053790_m1),
AQP1 (Hs01028916_m1), CD31 (Hs01065279_m1), CD34
(Hs00990732_m1), CD73 (Hs01573922_m1), CD90/THY1
(Hs00174816_m1), CXCR4 (Hs00607978_s1), ENG
(CD105) (Hs00923996_m1), GPC4 (Hs00155059_m1),
ITGAV (Hs00233808_m1), ITGB4 (Hs00236216_m1),
KLF4 (Hs00358836_m1), Nestin (Hs00707120_s1), and
Vimentin (Hs 00185584_m1) were used for the analyses. 10
minutes at 95°C, then 40 cycles at 95°C (15 s) and 60°C for
1 minute was set for the measurements. Analysis of the data
was done by the 2−ΔΔCt method. Fold change (relative quan-
tity) was determined relative to the expression level of the
native stromal tissue. 18S RNA (Hs03003630_g1) was used
as a housekeeping gene. All samples were run in triplicates.
2.6. Statistical Analysis. One-way ANOVA and Student’s
t-test were applied to reveal statistical diﬀerences between dif-
ferent groups. Signiﬁcance level was set to 0.95. p values less
than 0.05 (∗p < 0 05; ∗∗p < 0 01) were considered signiﬁcant.
3. Results
3.1. Cell Morphology and Proliferative Activity. Cultures
established by the enzymatic method (CD, PD) yielded CSCs
immediately, and these cells proliferated fast (Figure 2(a)),
reaching conﬂuence within 10–12 days (Figure 2(b)). The
explant cultures from the central and peripheral regions
(CE, PE) showed no microscopically observable proliferative
activity up until days 12–14, when the CSCs started actually
migrating and proliferating around the edges of the explants
(Figure 2(a)). The explant cultures reached conﬂuency by
days 20–25 after isolation (Figure 2(b)). No apparent
morphological diﬀerences were observed between the CSCs
produced from diﬀerent locations (center versus periphery)
and isolation technique (explant versus enzymatic digestion).
Ki-67 staining revealed a strong proliferative capacity of
the cells in both the explant and the digested cultures iso-
lated from the central and peripheral regions of the corneal
stroma (Figure 3(a)). From all stained cells, 4.21± 1.53%,
7.87± 4.73%, 8.60± 4.58%, and 10.95± 4.42% were positive
for Ki-67 (Figure 3(b)) for the four diﬀerent conditions:
CD, CE, PD, and PE, respectively (p = 0 43).
3.2. Immunoﬂuorescent Staining of the Native Corneal
Stroma. In order to ﬁrst demonstrate the diﬀerential expres-
sion patterns of cultured versus resident cells of the cornea,
the expression of markers for stemness, mesenchymal, epi-
thelial, endothelial cell origin, and extracellular matrix com-
ponents and adhesion proteins was carried out in the native
cornea (Figure 4 and Table 1, for a summary of the ﬁndings).
The anterior stroma is deﬁned as the ﬁrst 1/3 of the thickness
of the cornea proximal to the corneal epithelium, while pos-
terior stroma is deﬁned as the 2/3 thickness proximal to the
corneal endothelium (Figure S1).
Expression of ABCG2 and ABCG5 could not be detected
in situ in any of the corneal layers or regions. Strong and
similar staining for ALDH1A1 and α-actinin was observed
in the central and peripheral regions of the stroma. The
presence of CD34 was conﬁrmed by a strong signal coming
from all parts of the stroma in situ and CD31 was detected
as well. (Figure 4).
The expression of themajor stromal component, Collagen
I, showed strong positivity, while absence of Collagen IV
could be detected throughout the stroma. The triad of MSC
markers: CD73, CD90, and CD105 was negative throughout
the native cornea, andmarkers like Ki-67, CXCR4, andNestin
could not be detected in the tissue either. The presence of
Vimentin could be conﬁrmed in the stroma,while Fibronectin
appeared to be negative in the native corneal stroma. The
expression of an antireticulocyte, ﬁbroblast marker, and VE-
cadherin was also found negative in this tissue (Figure 4).
3.3. Surface Protein Expression Proﬁle of Cultured CSCs.
FACS analyses revealed a high expression of MSC markers:
CD73, CD90, and CD105, with no signiﬁcant diﬀerence
among the culture conditions (Figure 5 and Table S3).
Adhesion molecules CD51, CD49a, CD49d, and integrin-
related CD47 showed an increased expression, with no sig-
niﬁcant diﬀerence being detected between the conditions.
Putative stem cell markers ABCG2 and Nestin were posi-
tive, too, while CD34 and CD31 were negative. Statistical
analyses revealed no signiﬁcant diﬀerence in the expres-
sion of the latter proteins when comparing the various
isolation conditions used.
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3.4. Gene Expression Pattern in Cultured CSCs and Native
Corneal Stroma. CD73, CD90, and CD105/Endoglin were
signiﬁcantly expressed higher in the cultured CSCs compared
to the native stroma (14-, 95-, and 25-fold; p = 0 01,p < 0 01,
and p < 0 01, resp.). Furthermore, no diﬀerence could be
detected in the expression of the latter genes in the diﬀerent
regions isolated by the two methods. Expression of Vimentin
appeared to be 18-fold higher in the cultured CSCs compared
to the native stroma (p < 0 01) with no diﬀerence between the
various culture conditions. The expression of CD34 was
signiﬁcantly downregulated in cultured cells, as much as 5-
fold, when compared to the expression found in the native
tissue (p < 0 01). CD31 was signiﬁcantly downregulated in
cultured CSCs versus native cells (p < 0 01). Signiﬁcantly
lower expression of ALDH1A1 could be detected in the cul-
ture conditions compared to the native corneal stroma as
well (p < 0 01) (Figure 6).
ABCG2 was expressed 60-fold more in primary CSCs
compared to the native stromal cells (p < 0 01). Signiﬁcantly
lower expressions of AQP1, CXCR4, ITGB4, and KLF4 were
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Figure 2: Phase contrast images of corneal stroma cell cultures and respective growth rates. Pictures show days 1, 8, 15, and 21 of cultivation
for cells obtained from the central and peripheral regions of the stroma by enzymatic digestion and explant techniques (a). The scale bars
represent 1000 μm. The explanted tissue is marked by an asterisk (∗). Conﬂuency of the cultured cells %± SD was determined by ImageJ
measurements for each isolation technique (n = 3), and the points were plotted accordingly for the given values on the respective days (b).
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detected in the cultured CSCs compared to that of the native
tissue (p < 0 01, p < 0 01, p < 0 01, and p < 0 01, resp.), while
ITGAV and Nestin were signiﬁcantly upregulated in the
cultures (p < 0 01, p < 0 01). GPC4 expression was found to
be unaﬀected by culturing (p = 0 36).
4. Discussion
Cells derived from the corneal stroma can be a good source
for corneal research, drug testing, and future cell therapy
purposes in the eye or other organs [9, 16]. CSCs derived
from explants from the central part of the human corneal
stroma have been extensively characterized by us recently
[6]. These cells display MSC-like properties in vitro, includ-
ing trilineage diﬀerentiation potential and immunosuppres-
sive characteristics. Such features, however, appear not to
be characteristic of the resident cells in vivo. It is still debated
whether cells obtained from the stroma stem-like cells are
actually stromal keratocytes that undergo morphological
and functional changes or a diﬀerent small progenitor popu-
lation existent in vivo, which gets activated ex vivo.
The shortage of donor corneas worldwide [17] and the
availability of corneal rings remaining after keratoplasty in
many research groups worldwide justify a comparison and
clariﬁcation which of the diﬀerent sources or techniques for
isolating corneal stromal cells can be used. Most of the avail-
able tissue following surgery contains stroma from the
periphery, such as that remaining after penetrating kerato-
plasty, DMEK, or DSAEK procedures.
Immunostaining of the native corneal tissue revealed no
signiﬁcant diﬀerence in the expression of previously
described markers in the central versus peripheral parts of
the cornea. The native corneal stroma showed no expression
of the putative stem cell marker—the eﬄux protein
ABCG2—while a strong staining was observed in the cultures
from both the central and peripheral regions produced by
both techniques of isolation (explant versus enzymatic). This
diﬀerence in the expression found in the cultured CSCs ver-
sus the native cells could also be conﬁrmed at the gene
expression level. Upregulation of ABCG2 may result in a
stronger resistance of cultured cells to externally applied
therapy (e.g., chemotherapy), while cancerous cells have been
known to exploit use of such molecules to survive harsh con-
ditions [18, 19]. A population of murine adult stem cells
stained by Hoechst 33342 has been shown to discharge the
dye through ABCG2 and could be inhibited by verapamil
[20]. Similarly, a side population has been identiﬁed in the
human limbal epithelium [21]. No expression of another
member of the ATP-binding cassette transporter superfam-
ily, such as ABCG5, could be found in the native cornea.
Expression of ALDH1A1, a corneal crystalline, is
essential for the maintenance of transparency, downregula-
tion of which is associated with corneal haze [22]. Strong
staining was observed in the corneal stroma, which was
equally distributed along the central and peripheral regions
of the cornea. Interestingly, its expression was signiﬁcantly
downregulated in the culture conditions compared to the
native tissue.
All layers of the cornea expressed α-actinin, including the
stroma. Since keratocytes express this protein, the marker
should not be used alone for excluding presence of ﬁbroblas-
tic cells in vivo or ex vivo [23].
CD31 is usually expressed by vascular endothelial cells
and is likely to be involved in leukocyte migration. The role
of CD31 in the attraction and adhesion of polymorphonu-
clear cells in corneal wound healing has been demonstrated
before [24]; however, its role in an undamaged and purely
avascular tissue such as the native cornea remains unclear.
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Figure 3: Immunoﬂuorescent staining of nuclear Ki-67 in cultured cells. CSCs obtained from either the central or peripheral corneal stroma
by digestion and explant techniques have been cultured for 21–30 days, respectively, and stained for proliferation marker Ki-67. The
proliferation marker is shown in red with DAPI counterstaining (a). Relative quantity of Ki-67-positive cells (%)± SD is shown (b)
(p = 0 43). The scale bars represent 200 μm.
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Figure 4: Continued.
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Interestingly, the ex vivo cultured CSCs elicited no CD31
positivity by the means of isolation applied here. The
RT-qPCR analysis conﬁrmed a statistically signiﬁcant down-
regulation of CD31 in the cultured versus the native cells.
Little is known about the pleiotropic functions of CD34,
which is often referred to as the marker of hematopoietic
progenitors, while evidence suggests this marker to likely
function in immunological processes, such as regulating
migration and mobility of eosinophil granulocytes and
dendritic cells, as demonstrated in animal knockout experi-
ments [25]. Several studies have demonstrated the presence
of CD34 in keratocytes and its loss over the cultivation time
ex vivo [16, 26]. Strong staining of the corneal stroma could
indeed be detected in the native corneas, which was not the
Full thickness cornea Central cornea Peripheral cornea
CD105
Collagen I
Collagen IV
Fibronectin
Ki-67
Nestin
VE-Cadherin
Vimentin
(b)
Figure 4: Immunoﬂuorescent staining of normal human full thickness corneal sections. Images were acquired at 10x (left column) and 40x
(middle and right columns) magniﬁcations for each marker. Proteins and markers were stained by Alexa Fluor 488 conjugated secondary
antibodies (green). DAPI (blue) counterstaining was applied to visualize the cell nuclei.
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case in the cultured cells. Gene expression analysis further
supported this ﬁnding, and a 5-fold decrease in the expres-
sion of CD34 was observed in the cultured CSCs compared
to the native stroma. This is also in line with the ﬁndings of
others, which still leaves the function of this protein to be
further elucidated in the cornea [16]. Aquaporin-1 is an
important factor in keratocyte migration during wound heal-
ing, in vivo, which is downregulated, yet still expressed
in vitro in an animal model [27].
The triad of MSC markers—CD73, CD90, and
CD105—was found to be negative in situ, in contrast to the
strong positivity observed in all cultured cells ex vivo. The
same results were found when comparing the gene expres-
sion of the cultured versus native cells. These ﬁndings are
supported by recent ﬁndings in another independent study
[28], which shows the strong potential corneal stroma cells
have, as well as their ability to get activated upon cultivation
ex vivo. Gaining expression of the latter three proteins,
together with a loss of CD34 during ex vivo cultivation, is
what renders CSCs to have MSC-like phenotype, according
to the International Society for Cellular Therapy (ISCT).
Other types of MSCs of diﬀerent origin demonstrate similar
surface phenotype characteristics (high expression of CD90
and CD105) [29–32]. CD90 is believed to be involved in the
cellular adhesion to the matrix and other cells, inﬂammation,
ﬁbrosis, migration, and tumour growth, [33] while CD73 is
likely responsible for the immunosuppressive role of MSCs
[34]. This feature has been demonstrated by us recently, as
well as [6]. These molecules are retained over long-term
and multiple passages on the cells, as demonstrated by us
and others equally [35].
Characterizing the extracellular matrix which makes the
backbone of the cornea is also very important to elucidate
the diﬀerence between the corneal stroma cells in vivo, while
in their niche, and ex vivo. Abundance of the major compo-
nent of the corneal stroma, Collagen I, was indeed found
throughout the native stroma, while Collagen IV was absent.
Integrin αV (CD51) was found to be expressed on cultured
cells and an upregulation was observed at a gene level, while
Integrin β4 was signiﬁcantly downregulated ex vivo com-
pared to in situ.
These ﬁndings further strengthen the cultured cells
respond to a change in the environmental niche surrounding
them, which is likely compensated by deposition of de novo
synthesized collagen ex vivo (data not shown).
Fibronectin was also not present in the native, intact
corneas, which conﬁrms the corneal wound healing proper-
ties of this extracellular matrix component. Deposits of
Fibronectin have been shown to appear in the epithelium
and stroma soon after penetrating trauma, although it
disappears over the course of two weeks [36].
The presence of Ki-67 could not be detected in the native
corneal sections either. This further conﬁrms there was no
trauma aﬀecting the control, native epithelium, or the other
layers of the cornea, thus indicating presence of induced cell
proliferation, although both explant and enzymatic tech-
nique generated cultures from the diﬀerent corneal regions
displayed actively proliferating Ki-67-positive cells.
The mesenchymal marker Vimentin was found to be
expressed in the stroma. This is in line with the ﬁndings of
others. Vimentin has also been shown in knockdown studies
to cause development of corneal haze [37]. The neural
stemness marker Nestin could not be detected in the native
corneal stroma. This protein is known to be expressed in
spherical cultures generated from murine corneas, while
putative precursorNestin-positivepopulationhasbeen shown
previously in the peripheral cornea of rabbits [38, 39].
Nestin was found to be upregulated in the cultured cells
when compared to the native tissue. The protein is expressed
in proliferating cells and is believed to have a role in the
reorganization of intermediate ﬁlaments.
KLF4, an important stemness marker, has been associ-
ated with tissues exposed to the outside world [40]. The
cornea is the ﬁrst and most important mechanical barrier
of the eye. We hereby show a decreased gene expression of
KLF4 in cultured CSCs, compared to the native stroma.
The putative stem cell migratory/homing marker CXCR4
[41, 42] was not detected in situ by immunostaining, while
low levels were detected by PCR. Others reported similar,
low amounts of the functional CXCR4 in cultured MSCs,
but blocking the molecule has led to a decreased homing
response to bone marrow [43]. CXCR4 has also been impli-
cated in the invasion of malignant cells and epithelial-
mesenchymal transition (EMT) [44].
Altogether, a general upregulation of stemness and mes-
enchymal cell markers was observed in the ex vivo cultivated
CSCs, with a downregulation of function-related molecules,
which should all be considered when treating such cells as
Table 1: Distribution of corneal stroma markers in the various
corneal regions.
Marker
Peripheral
stroma
Central
stroma
Anterior
stroma
Posterior
stroma
ABCG2 − − − −
ABCG5 − − − −
ALDH1A1 ++ ++ ++ +
α-Actinin ++ ++ ++ +
CD31 + + + +
CD34 ++ ++ ++ ++
CD73 − − − −
CD90 − − − −
CD105 − − − −
Collagen I ++ ++ ++ ++
Collagen IV − − − −
CXCR4 − − − −
Fibroblast
marker
− − − −
Fibronectin − − − −
Ki-67 − − − −
Nestin − − − −
VE-Cadherin − − − −
Vimentin ++ ++ ++ ++
“−” stands for no staining, “+” for a medium intensity signal, and “++” for a
strong staining.
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MSCs. The potential of corneal stromal cells has been
demonstrated numerous times in animal studies before;
however, it seems like certain compromises should be made
when using such cells as part of in vitro study models, due
to the striking diﬀerences in vivo and in vitro.
The present study shows no phenotypic or genotypic
diﬀerence between CSCs produced by the digestion or
explant methods from the central or peripheral regions of
the cornea. However, the gene expression and protein proﬁle
of native corneal stroma cells compared to ex vivo expanded
CSCs shows that the latter likely adapt from an in vivo
extracellular matrix niche to an adopted environment and
presence of serum in the culture medium. Such a change in
the expression proﬁle shows how dynamic corneal stroma
cells can be to the environmental niche and likely to wounds
or inﬂammation on the surface of the eye and intracorneally.
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Figure 5: Percent of positive cells for given surface markers in the four diﬀerent conditions± SD is shown (a) (n = 3). Representative
histograms of the FACS analysis, showing a PE donor, with the respective isotype controls, depicted in white color, with the stated
antibodies in red, after Overton histogram subtraction (% of positive cells is shown) (b).
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It remains to be further examined whether such changes are
reversible, or if it is beneﬁcial for the cells to change their
gene and protein expression if used for treatment of corneal,
eye, or other conditions in human cell therapy. Most likely, a
future biopsy taken from any part of a healthy live donor,
despite the procedure being invasive, could yield viable,
expanding populations of stromal cells exhibiting mesenchy-
mal stem cell-like properties.
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